#LN Market Insights 2030
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Total funding amounts to $125.3M.
Text
0 notes
Text
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by 2030, claims Roots Analysis
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings.
Given the frequently reported inadequacies of conventional cancer therapies and the growing need for personalized medicine, there is a marked surge in the demand for TIL-based therapies. In addition, the clinical success in this domain is likely to draw in investments that will support ongoing and anticipated therapy development initiatives.
To order this 255+ page report, which features 90+ figures and 100+ tables, please visit
https://www.rootsanalysis.com/reports/til-therapies-market.html
Key Market Insights
Over 80 TIL-based therapies are currently under development
Close to 55% of the aforementioned candidates are being evaluated in clinical stages (phase I/II and above), while more than 20% therapies are in preclinical and discovery stages. Examples of late-stage clinical candidates include CCRT+TIL, Lifileucel, LTX-315 and TILs, and IOV-2001 and LN-145.
More than 80% pipeline candidates are presently being developed to target solid tumors
T-cell immunotherapy developers were observed to be primarily focused on the treatment of different oncological indications. It is worth noting that 17% pipeline candidates are being developed for the treatment of both hematological and solid tumors.
Partnership activity within this domain has increased at a CAGR of 45%, between 2011 and 2020
The maximum partnerships related to TIL-based therapies were inked in the period 2017-2019. Majority of partnership deals signed within this domain were R&D agreements (33%), followed by technology licensing (20%) and manufacturing (15%) agreements.
Over USD 2 billion has been invested by both private and public investors, across 30 instances
It is important to mention that, between 2013 and 2020, majority of the funding amount was raised through other equity financing elements (33%), venture capital rounds (30%) and secondary offerings (20%).
This market is anticipated to grow at a CAGR of 60.6%, during the period 2021-2030
Growth in this domain is anticipated to be primarily driven by encouraging clinical trial results and likely approval of some advanced stage therapy candidates. Further, North America (primarily the US) and Europe are expected to capture over 90% of the market share (in terms of sales-based revenues) by 2030.
To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/til-therapies-market.html
Key Questions Answered
§ What are the prevalent R&D trends related to TIL-based therapies?
§ Who are the leading industry and non-industry players engaged in the development of TIL-based therapies?
§ What challenges are commonly faced by stakeholders engaged in this domain?
§ Who are the key investors in this domain?
§ Who are the key opinion leaders / experts engaged in this upcoming field of therapeutics?
§ Which types of partnership models are commonly adopted by industry stakeholders?
§ Which regions are key contract manufacturing hubs for TIL-based therapies?
§ Which factors are likely to influence the evolution of this upcoming market?
§ How is the current and future market opportunity likely to be distributed across key market segments?
The USD 4.3+ billion (by 2030) financial opportunity within the TIL-based therapies market has been analyzed across the following segments:
§ Target Indication
§ Acute Lymphoblastic Leukemia
§ Melanoma
§ Others
§ Key Players
§ Key Geographical Regions
§ North America
§ Europe
§ Asia Pacific
The research includes brief profiles, featuring an overview of the company, its financial information (if available), details related to its product(s), highlighting type of therapy and current development status, technology portfolio (if available), recent developments and manufacturing capabilities.
§ Cellular Biomedicine Group
§ Iovnace Biotherapeutics
§ Lytix Biopharma
§ Phio Pharmaceuticals
For additional details, please visit
https://www.rootsanalysis.com/reports/til-therapies-market.html or email [email protected]
You may also be interested in the following titles:
1. Global T-Cell Therapies Market (5th Edition): Industry Trends and Global Forecasts, 2021-2030
2. CAR-T Cell Therapies Market (3rd Edition): Industry Trends and Global Forecasts, 2021-2030
3. TCR-based Therapies Market: Industry Trends and Global Forecasts, 2021-2030
4. Cell and Gene Therapy CROs Market: Industry Trends and Global Forecasts (2nd Edition), 2021-2030
5. Gene Therapy Market (4th Edition): Industry Trends and Global Forecasts, 2020-2030
Contact Details
Ben Johnson
+1 (415) 800 3415
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
0 notes
Text
Cryopreservation for In-vitro Fertilization (IVF) Market is set to reflect an impressive 10.2% CAGR through 2030
A recent market study published by Future Market Insights (FMI) on the cryopreservation for in-vitro fertilization (IVF) market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the cryopreservation for in-vitro fertilization (IVF) market, growth prospects are obtained with maximum precision.
Cryopreservation for In-vitro Fertilization (IVF) Market: Segmentation
The global cryopreservation for in-vitro fertilization (IVF) market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Product Type
Cryopreservation Media
Cryopreservation Storage Devices
Dewars
Cryogenic Liquid Cylinders
Cryogenic Storage Tanks
Storage Container
Consumables & Accessories
Cryo-Shipping
Vapor Tanks
Storage Alarm Systems
LN 2 Auto Fill Systems
LN2 Sterilization System
Cryo Control/Inventory Management Systems
Cryocanes
Visotubes
Cannisters
Vitrification Carriers
Sperm Straws
Saw Freeze Straws
Cryovials
Dry Shipper Container
Clinical Pack Over Wrap
Cryogenic Labels
Application
Oocycte Cryopreservation
Sperm Cryopreservation
Embryo Cryopreservation
End User
Biobanks
IVF & Fertility Clinics
Research & Academic Institutes
Cryo-shipping/couriers
Cryo Monitoring /Inventory Management
Regional Outlook
North America (US, Canada)
Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
Europe (Germany, UK, Russia, France, Italy, Spain, BENELUX, Rest of Europe)
South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)
East Asia (China, Japan, and South Korea)
Oceania (Australia, New Zealand)
Middle East & Africa (GCC Countries, Turkey, South Africa, and Rest of MEA)
Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12785
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
Report Chapters
Chapter 01 – Executive Summary
The report initiates with the executive summary of the cryopreservation for in-vitro fertilization (IVF) market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the cryopreservation for in-vitro fertilization (IVF) market.
Chapter 02 – Market Overview
Readers can find the definition and a detailed segmentation of the cryopreservation for in-vitro fertilization (IVF) market in this chapter, which will help them understand the basic information about the market.
Chapter 03 – Key Market Trends
This chapter highlights the key trends impacting the growth of the cryopreservation for in-vitro fertilization (IVF) market over the forecast period. This chapter helps reader to understand the trends of cryopreservation for in-vitro fertilization (IVF) market.
Chapter 04 – Key Success Factors
This section includes key success factors such as product adoption analysis, application road map, key promotional strategies, regulations, and many more. This section helps readers understand the key factors associated with the cryopreservation for in-vitro fertilization (IVF) market.
Chapter 05 – Market Background
This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis that are expected to influence growth of the cryopreservation for in-vitro fertilization (IVF) market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
Any Queries, Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-12785
Why Future Market Insights?
Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the In Vitro Fertilization Banking Services Market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
Visit More Healthcare Reports:
Gene Editing Tools Market: Gene Editing Tools Market: Profitable Technology Transfer for CRISPR to Boost Revenues: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
Venous Thromboembolism Treatment Market: Venous Thromboembolism Treatment Market: US Remains the Front Runner Driven by Favorable Reimbursement Scenario: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
Bone Growth Stimulators Market: Bone Growth Stimulators Market: Fractures & Spinal Fusion Surgeries Continue to Generate Sizeable Demand: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
0 notes
Text
Cervical Cancer Market
Cervical Cancer occurs in the cells of the cervix and usually originates in the transformation zone of the cervix, and spreads to regional lymph nodes with parametrial invasion also common.
Most cases of cervical cancer are caused by infection with human papillomavirus (HPV). Apart from HPV, other factors that can also increase the risk include: human immunodeficiency virus (HIV), chlamydia, smoking, obesity, family history of cervical cancer, diet low in fruits and vegetables, taking birth control pills, and having three full-term pregnancies.
DelveInsight's "Cervical Cancer Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Cervical Cancer, historical and forecasted epidemiology as well as the Cervical Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some facts of the Cervical Cancer Market Report:
The incidence of cervical cancer in 7MM (US, UK, Germany, Italy, Spain, France & Japan) in 2020 is expected to be 43,712.
In the 7MM, the USA is the major contributor to the cervical cancer market revenue in 2020, and the region is expected to hold its position in the upcoming years.
Key companies propelling the market size include Regeneron, AstraZeneca, Lovance, Zeria Pharmaceutical, Seattle Genetics/Genmab, Agenus Bio, Roche, Akeso Biopharma and Vaccibody/Roche, among others.
Launch of cervical cancer pipeline therapies, including Cemiplimab (Regeneron), Durvalumab (AstraZeneca), LN-145 (Iovance), Z-100 (Zeria Pharmaceutical), Tisotumab vedotin (Seattle Genetics/Genmab) in the next decade is expected to propel the market growth.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/cervical-cancer-market
“As per WHO estimates, Cervical Cancer is the fourth most common cancer in women.”
Clinical presentation depends mainly on the location and extent of disease. Precancerous changes or very early stage disease are usually asymptomatic and are detected on a cervical smear. Symptoms usually appear when the tumour causes spontaneous or contact bleeding, or pain if lymph nodes are involved.
Typical cervical cancer symptoms are: unusual bleeding, such as in between periods, after sex, or after menopause, vaginal discharge that looks or smells different than usual, pain in the pelvis, needing to urinate more often, pain during urination etc.
All women are at risk for cervical cancer. It occurs most often in women over age 30. There’s more than one kind of cervical cancer.
Squamous cell carcinoma-This forms in the lining of cervix. It’s found in up to 90% of cases.
Adenocarcinoma-This forms in the cells that produce mucus.
Mixed carcinoma-This has features of the two other types.
DelveInsight estimated that cervical cancer is most often diagnosed in women between the ages of 35 and 44, with the average age at diagnosis being 50. The late diagnosis in women is a consequence of a lack of vaccination and screening in women in the early stages of their lives.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/cervical-cancer-market
Some of the Cervical Cancer Companies are:
Regeneron Pharmaceuticals
Zeria Pharmaceutical
Advaxis
AstraZeneca
Immunitor
And Many Others
Cervical cancer Drug Covered:
Libtayo
Z-100
ADXS11–001
IMFINZ
V3-Cervix
And Many Others
Table of Contents:
1. Key Insights
2. Executive Summary of Cervical Cancer
3. Competitive Intelligence Analysis for Cervical Cancer
4. Cervical Cancer: Market Overview at a Glance
5. Cervical Cancer: Disease Background and Overview
6. Patient Journey
7. Cervical Cancer Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Cervical Cancer Treatment
11. Marketed Products
12. Emerging Therapies
13. Cervical Cancer: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Cervical Cancer
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Request for Detailed TOC: https://www.delveinsight.com/sample-request/cervical-cancer-market
Other Reports:
Intrahepatic Cholangiocarcinoma Market
Barett Esophagus Market
Aortic Stenosis Market
Chemotherapy Induced Diarrhea Market
Immunologic Deficiency Syndrome Market
Binge Eating Disorder Market
#Cervical Cancer market report#Cervical Cancer symptoms#Cervical Cancer Launch Insight#Cervical Cancer Epidemiology#Cervical Cancer treatment#Cervical Cancer market forecast#Cervical Cancer market trends
0 notes
Text
Cryopreservation for IVF Market Report Explored in Latest Research 2020-2030
A recent market study published by Future Market Insights (FMI) on the cryopreservation for in-vitro fertilization (IVF) market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the cryopreservation for in-vitro fertilization (IVF) market, growth prospects are obtained with maximum precision.
Cryopreservation for In-vitro Fertilization (IVF) Market: Segmentation
The global cryopreservation for in-vitro fertilization (IVF) market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Product Type
Vapor Tanks
Storage Alarm Systems
LN 2 Auto Fill Systems
LN2 Sterilization System
Cryo Control/Inventory Management Systems
Cryocanes
Visotubes
Cannisters
Vitrification Carriers
Sperm Straws
Saw Freeze Straws
Cryovials
Dry Shipper Container
Clinical Pack Over Wrap
Cryogenic Labels
Application
Oocycte Cryopreservation
Sperm Cryopreservation
Embryo Cryopreservation
End User
Biobanks
IVF & Fertility Clinics
Research & Academic Institutes
Cryo-shipping/couriers
Cryo Monitoring /Inventory Management
Regional Outlook
North America (US, Canada)
Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
Europe (Germany, UK, Russia, France, Italy, Spain, BENELUX, Rest of Europe)
South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)
East Asia (China, Japan, and South Korea)
Oceania (Australia, New Zealand)
Middle East & Africa (GCC Countries, Turkey, South Africa, and Rest of MEA)
Report Chapters
To Get the Sample Copy of Report visit @https://www.futuremarketinsights.com/reports/sample/rep-gb-12785
Chapter 01 – Executive Summary
The report initiates with the executive summary of the cryopreservation for in-vitro fertilization (IVF) market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the cryopreservation for in-vitro fertilization (IVF) market.
Chapter 02 – Market Overview
Readers can find the definition and a detailed segmentation of the cryopreservation for in-vitro fertilization (IVF) market in this chapter, which will help them understand the basic information about the market.
Chapter 03 – Key Market Trends
This chapter highlights the key trends impacting the growth of the cryopreservation for in-vitro fertilization (IVF) market over the forecast period. This chapter helps reader to understand the trends of cryopreservation for in-vitro fertilization (IVF) market.
Chapter 04 – Key Success Factors
This section includes key success factors such as product adoption analysis, application road map, key promotional strategies, regulations, and many more. This section helps readers understand the key factors associated with the cryopreservation for in-vitro fertilization (IVF) market.
Chapter 05 – Market Background
This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis that are expected to influence growth of the cryopreservation for in-vitro fertilization (IVF) market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
Ask an Analyst @https://www.futuremarketinsights.com/ask-question/rep-gb-12785
Chapter 06 – Global Cryopreservation for In-vitro Fertilization (IVF) Market: COVID19 Impact Analysis
This section highlights COVID19 impact analysis that are expected to influence growth of the cryopreservation for in-vitro fertilization (IVF) market over the forecast period. This section helps reader to understand the COVID19 crisis impact on the market across various regions.
Chapter 07 – Global Cryopreservation for In-vitro Fertilization (IVF) Market: Pricing Analysis
This section highlights the global cryopreservation for in-vitro fertilization (IVF) market pricing analysis by product. This section helps reader to understand the pricing variation of whole slide scanner in various geography.
Chapter 08 – Global Cryopreservation for In-vitro Fertilization (IVF) Market Value Analysis 2015-2019 & Opportunity Assessment 2020-2030
This section explains the global market value analysis and forecast for the cryopreservation for in-vitro fertilization (IVF) market during the forecast period. This chapter includes a detailed analysis of the historical cryopreservation for in-vitro fertilization (IVF) market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).
Chapter 09 – Global Cryopreservation for In-vitro Fertilization (IVF) Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Product
Based on product, the cryopreservation for in-vitro fertilization (IVF) market is segmented into cryopreservation media, cryopreservation storage devices (dewars, cryogenic liquid cylinders, cryogenic storage tanks (vapor tanks, storage alarm systems, LN2 auto fill systems, LN2 sterilization systems, cryo control/inventory management systems), and storage container (cryocanes, visotubes, cannisters)), consumables & accessories (vitrification carriers, sperm straws, slow freeze straws, and cryovials), cryo-shipping (dry shipper container, clinical pack over-wrap, and cryogenic labels). In this chapter, readers can find information about the key trends and developments in cryopreservation for in-vitro fertilization (IVF) market and market attractiveness analysis based on product.
Buy this report @https://www.futuremarketinsights.com/checkout/12785
Chapter 10 – Global Cryopreservation for In-vitro Fertilization (IVF) Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Application
This chapter provides details about the cryopreservation for in-vitro fertilization (IVF) market based on application, and has been classified into oocyte cryopreservation, sperm cryopreservation, and embryo cryopreservation. In this chapter, readers can understand the market attractiveness analysis based on application.
so on..
0 notes
Text
Cervical Cancer Market is Expected to Increase With a CAGR of 16.9% for the Study Period of 2017-2030 in 7MM: DelveInsight
Cervical Cancer Market is Expected to Increase With a CAGR of 16.9% for the Study Period of 2017-2030 in 7MM: DelveInsight
LAS VEGAS, US (DelveInsight)-- The coming decade is expected to witness a rise in targeted therapies in the pipeline and a better drug delivery approach that shall give the cervical cancer market a boost. An increase in cervical cancer incidence is also a major reason behind the accelerated momentum of the cervical cancer market size growth. Further, increased healthcare spending, better diagnosis, and heightened R&D to facilitate a better understanding and increased awareness of the disease are some other driving factors.
View report: https://www.delveinsight.com/report-store/cervical-cancer-market
Some of the key insights from cervical cancer market report:
The incidence of cervical cancer in 7MM (US, UK, Germany, Italy, Spain, France & Japan) in 2020 is expected to be 43,712.
In the 7MM, the USA is the major contributor to the cervical cancer market revenue in 2020, and the region is expected to hold its position in the upcoming years.
Key companies propelling the market size include Regeneron, AstraZeneca, Lovance, Zeria Pharmaceutical, Seattle Genetics/Genmab, Agenus Bio, Roche, Akeso Biopharma and Vaccibody/Roche, among others.
Launch of cervical cancer pipeline therapies, including Cemiplimab (Regeneron), Durvalumab (AstraZeneca), LN-145 (Iovance), Z-100 (Zeria Pharmaceutical), Tisotumab vedotin (Seattle Genetics/Genmab) in the next decade is expected to propel the market growth.
Get a cervical cancer sample copy or download a cervical cancer infograph: www.delveinsight.com/sample-request/cervical-cancer-market
View report: https://www.delveinsight.com/report-store/cervical-cancer-market
Cervical cancer is a cause of infection from Human papillomavirus (HPV), which can be prevented. Due to its slow progression, the precancerous cells can be detected through proper screening with a Pap smear test and HPV test; and can be prevented through HPV vaccination (Cervarix and Gardasil 9). However, a lack of awareness and misconceptions hinder screening and its early diagnosis.
DelveInsight estimated that cervical cancer is most often diagnosed in women between the ages of 35 and 44, with the average age at diagnosis being 50. The late diagnosis in women is a consequence of a lack of vaccination and screening in women in the early stages of their lives.
For cancer, which is preventable in the first place, the mortality rate due to advanced cervical cancer is relatively high. However, the rate varies with the different stages of cancer, geographies, ethnicities, and age-groups.
To know more about Cervical Cancer Incidence, Diagnosis and Mortality Visit: https://www.delveinsight.com/report-store/cervical-cancer-market
View report: https://www.delveinsight.com/report-store/cervical-cancer-market
The cervical cancer epidemiology section in the report provides historical and forecasted analysis upto 2030 segmented by:
Incident cases of Cervical Cancer
Stage-specific Incidence of Cervical Cancer
Histopathologic Types of Cervical Cancer
Age-specific causes of Cervical Cancer
The present treatment market for cervical cancer is mainly bifurcated into therapeutics and preventive. The preventive cervical cancer treatment market comprises two candidates, namely Cervarix (Merck) and Gardasil (GlaxoSmithKline).
For advanced, metastatic cervical cancer, the available treatments in the market constitute traditional chemotherapies, targeted monoclonal antibodies, biosimilars, and immunotherapies. Targeted therapies such as Avastin have revolutionized the treatment landscape for cervical cancer, which are often given in combination with chemotherapy. Avastin has enjoyed market exclusivity and has been a top-earner of Roche. However, after its patent expiry in 2019 in the US, it faced rigorous competition from Amgen's Mvasi, Pfizer's Zirabev, and Samsung's Aybintio. The sales of the therapy have declined in the US due to the approvals of copycats, which are priced considerably lower than the original one. The sales of the drug will decline in the European market in January 2022 due to a similar fate.
View report: https://www.delveinsight.com/report-store/cervical-cancer-market
The cervical cancer market also homes Merck's star, Keytruda, which got approval in 2018 for advanced cervical cancer for PD-L1 positive patients. Keytruda is the only approved immunotherapy in the cervical cancer market landscape; hence it enjoys the monopoly in the domain. However, sooner it will be vying for dominance as Regeneron and Sanofi's contender Libtayo is proceeding towards the finish line. Furthermore, to minimize the effect of inevitable patent expiry, Merck is testing a combination of Keytruda with Chemoradiotherapy for patients with high-risk locally advanced cervical cancer (NCT04221945). Enrolment is ongoing for Phase III, and the study is expected to be completed by the end of 2024.
Recently, at ASCO 2020, Genmab demonstrated the positive benefit-to-risk profile of its drug Tisotumab vedotin, a first-in-class antibody-drug conjugate directed against tissue factor (TF). Now the company plans to investigate the drug in combination with other cancer drugs, namely Bevacizumab, Pembrolizumab, and Carboplatin in a Phase Ib/II trial to find out the correct dosage in recurrent or metastatic cervical cancer (NCT03786081).
The Cervical cancer market has several treatment drugs in the late-stage as well as early phase of development in the pipeline. The expected launch of pipeline therapies in the foreseeable future shall significantly impact the Cervical cancer market. A better understanding of the HPV and its interaction with the host has given rich insights into the therapeutic domain.
Further, the launch of prophylactic as well as therapeutic vaccines, will transform the cervical cancer treatment landscape. Prophylactic cancer vaccines have been successful in dampening the disease burden; however, they cannot help the patients with established tumors, which Scientists believe can be tackled by the use of therapeutic vaccines. However, the neoantigens that are the basis of the therapeutic cancer vaccine are unique to patients thus, it requires the development of personalized therapies. Among all the candidates in the distant pipeline, only one to reach Phase III is VGX-3100, a candidate of Inovio Pharmaceuticals.
Also, research is underway to identify therapeutic targets and develop curative therapy to treat cervical cancer. Scientists are investigating the potential of biomarkers among cervical cancer patients that shall define the screening and diagnosis of cancer to a greater extent. A combination of multiple potential biomarkers, including serum proteins, microRNAs, ctDNA mutations, and others, can significantly increase the sensitivity of the screening and detection of cervical cancers.
View report: https://www.delveinsight.com/report-store/cervical-cancer-market
Although cervical cancer market growth may face obstructions in the face of lack of awareness among common people, delayed diagnosis, high cost of treatment, and palliative treatment options for metastatic cancer. Nevertheless, the renewed interest in targeted therapies, personalized medicine, and rising R&D that has facilitated the identification of actionable biomarkers offer a promising and flourishing environment to the global cervical cancer market.
Scope of the Report
Geography Covered: 7MM - The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan.
Study Period: 3-year historical and 11-year forecasted analysis (2017-2030).
Markets Segmentation: By Geographies, By Therapies (Forecasted + Historical).
Companies Covered: Regeneron, AstraZeneca, Iovance, Zeria Pharmaceutical, Seattle Genetics/Genmab, Agenus Bio, Roche, Akeso Biopharma, and Vaccibody/Roche among others.
Analysis: Comparative and conjoint analysis of emerging therapies, Attribute Analysis,
Case Studies
KOL's Views
Analyst's View
Request for Webex demo: https://www.delveinsight.com/report-store/cervical-cancer-market
Table of Contents
1
Key Insights
2
Executive Summary of Cervical Cancer
3
SWOT Analysis of Cervical Cancer
4
Cervical Cancer Epidemiology Overview at a Glance
5
Cervical Cancer Market Overview at a Glance
6
Disease Background and Overview: Cervical Cancer
7
Epidemiology and Patient Population
8
Country Wise-Epidemiology of Cervical Cancer
9
Cervical Cancer Treatment and Management
10
Unmet Needs in the Cervical Cancer Market
11
Cervical Cancer Marketed Therapies
12
Cervical Cancer Emerging Therapies
13
Cervical Cancer: Other Promising Therapies
14
Cervical Cancer 7 Major Market Analysis
15
7MM Cervical Cancer Country-Wise Analysis
16
Cervical Cancer Market Drivers
17
Cervical Cancer Market Barriers
18
Appendix
19
DelveInsight Capabilities
20
Disclaimer
21
About DelveInsight
*The TOC is illustrative, request for a detailed TOC.
Related Report
Cervical Intraepithelial Neoplasia Market Insight, Epidemiology and Market Forecast -2030
Cervical Intraepithelial Neoplasia (CIN) or cervical dysplasia is a precancerous condition characterized by an unusual growth of the cells on the surface lining of the cervix or endocervical canal.
The report proffers a detailed section of the indication overview, signs symptoms, with a major focus on CIN epidemiology in the 7MM, present treatment modalities, and emerging therapies in the pipeline. The report lays down an in-depth understanding of the market landscape, key collaborations, partnerships, R&D development, and driving forces as well as restrains in the market growth.
Human Papillomavirus (HPV) Associated Disorders- Market Insight, Epidemiology and Market Forecast -2030
Human Papillomavirus virus (HPV) is a cause of a significant burden on global healthcare. HPV infections, if neglected, can results in several diseases, including anogenital warts and recurrent respiratory papillomatosis and several forms of cancers.
The report provides rich insights into the indication, its etiology, pathogenesis, manifestation with an exclusive focus on historical as well as forecasted epidemiology and market trends. The report brings a comprehensive analysis of the market landscape, recent happenings, breakthroughs, key partnerships, present and emerging treatments, market barriers, and drivers.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Contact Us:
Shruti Thakur [email protected] +1(919)321-6187
www.delveinsight.com
0 notes